药物发现,开发和制造 499条(本栏目收费,不能显示细节,电话15274084725)
PHYSIOLOGICALLY BASED
PHARMACOKINETIC MODELING 2541
MATHEMATICAL MODELING AS A
NEW APPROACH FOR IMPROVING
THE EFFICACY/TOXICITY
PROFILE OF DRUGS: THE
THROMBOCYTOPENIA CASE STUDY 2603
REGULATORY REQUIREMENTS FOR
IND s / FIH (FIRST IN HUMAN) STUDIES 2641
PRECLINICAL DRUG
DEVELOPMENT PLANNING 2697
USE OF PROJECT TEAMS IN
PRECLINICAL DEVELOPMENT 2761
RELATIONSHIP BETWEEN ANIMAL
MODELS AND CLINICAL RESEARCH:
USING MUCOSITIS AS A
PRACTICAL EXAMPLE 2777
BACTERIAL MUTATION ASSAY 2805
IN VITRO MAMMALIAN CELL
MUTATION ASSAYS * 2825
IN VITRO MAMMALIAN
CYTOGENETIC TESTS 2851
IN VIVO GENOTOXICITY ASSAYS 2865
REPEAT DOSE TOXICITY STUDIES 2909
IRRITATION AND LOCAL TISSUE
TOLERANCE STUDIES IN
PHARMACETICAL SAFETY
ASSESSMENT 2929
SAFETY ASSESSMENT STUDIES:
IMMUNOTOXICITY 2965
IMMUNOTOXICITY TESTING:
ICH GUIDELINE S8 AND
RELATED ASPECTS 3019
REPRODUCTIVE AND
DEVELOPMENTAL TOXICOLOGY 3059
CARCINOGENICITY STUDIES 3119
TOXICOKINETICS: AN INTEGRAL
COMPONENT OF PRECLINICAL
TOXICITY STUDIES 3155
IN VITRO TOXICOKINETICS AND
DYNAMICS: MODELING AND
INTERPRETATION OF TOXICITY DATA 3205
TOXICOLOGIC PATHOLOGY 3247
SECONDARY PHARMACODYNAMIC
STUDIES AND IN VITRO
PHARMACOLOGICAL PROFILING 3277
CURRENT PRACTICES IN
SAFETY PHARMACOLOGY 3307
SAFETY ASSESSMENT OF
BIOTECHNOLOGY - DERIVED
THERAPEUTICS 3391
PRECLINICAL DEVELOPMENT
OF PROTEIN PHARMACEUTICALS:
AN OVERVIEW 3409
THE PHARMACOGENOMICS OF
PERSONALIZED MEDICINE 3437
TOXICOGENOMICS IN PRECLINICAL
DEVELOPMENT 3563
TOXICOPROTEOMICS:
PRECLINICAL STUDIES 3607